Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
PR Newswire

Unite Reaction to Scottish Ambulance Service Inquiry

— LONDON, May 29

LONDON, May 29 /PRNewswire/ -- Unite, Scotland's largest trade union, has welcomed this afternoon's announcement that an inquiry will take place into the management of the Scottish Ambulance Service.

Over the last few weeks, Unite has expressed its concerns about the deterioration of its relations with Scottish Ambulance Service management. The Union believe that management practices have resulted in a culture of bullying and harassment that is to the detriment of staff morale and patient care.

Unite Senior Industrial Officer, Jimmy Farrelly said, "We welcome the moves taken today by the board of the Scottish Ambulance Service which we believe are a direct response to the concerns we have raised.

"Unite will fully co-operate with the inquiry over the coming weeks to ensure the concerns of the staff are addressed and crucially that patient care remains the priority throughout."

Unite has over 1,400 members in the Scottish Ambulance Service ranging from paramedics to control staff, technicians to ancillary staff.

Related news

Partnering consultation free of charge
BioPharm America
Need competitive intelligence information
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us